SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Protein Polymer (PPTI)

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Paul Cohen who wrote ()6/14/1996 7:32:00 PM
From: Fred J Bealle   of 11
 
Paul, I websearched and found following at www.sddt.com:
There is more I did not copy.
PPTI has had good backing, lost lots, details to May 95 are on web page. Seems like sound product. Maybe too late to profit, if hitting new highs.
fred b.

attach:

J. Thomas Parmeter
Protein Polymer Technologies Inc.

Jan. 23, 1995

Johnson & Johnson Development Corp. and several private investors made an equity investment of $2.2 million in Protein
Polymer Technologies Inc. The cash infusion increased assets in the developmental-stage company to $3.6 million and will
finance operations into late 1995.

"The key to our continued progress will be alliances such as the one completed with J&J," says J. Thomas Parmeter, CEO.
"We expect such alliances to allow us to bring our products to the marketplace in a relatively rapid and efficient manner."

PPTI was spun off from Syntro Corp. in 1988. Syntro developed the genetically engineered protein polymer technology on
which PPTI is built.

The Sorrento Valley firm develops synthetic material that can be used for bone-bonding and other medical purposes. These
materials can be developed as biocompatible elements suitable for stabilizing bone and orthopedic implants and coating
internally residing medical devices and implants such as heart valves and vein grafts.

Commercial sales of one of the products, ProNectin-F, began in 1991. In 1992 the U.S. Patent Office notified the company
that it would grant PPTI a fundamental patent based on technological breakthroughs which made the production of protein
polymers possible.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext